Ultrasound detects AMD differences

Article

Wavelet augmented ultrasound effectively detects differences in choroidal microarchitecture in eyes with wet and dry AMD, according to a recent paper.

Wavelet augmented ultrasound effectively detects differences in choroidal microarchitecture in eyes with wet and dry AMD, according to a recent paper.

The prospective case series headed by Dr D. Jackson Coleman, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Centre, New York, USA, included 69 eyes of 52 patients. The signal from the retina and choroid was extracted via digitized 20 MHz B-scan radiofrequency ultrasound data.

Statistical modelling applied to the wavelet coefficients assessed differences between dry, wet and non-AMD eyes, while receiver operating characteristic (ROC) analysis was adapted to evaluate a multivariate classifier.

The group discovered that 18 patients did not have AMD, 23 had dry AMD and 28 had wet AMD. Multivariate models presented statistically significant differences between groups and multiclass ROC analysis revealed an excellent volume-under-curve of 0.892±0.17.

Ultrasound is highly sensitive to the organizational elements of choroidal microarchitecture with regards to scatter and fluid tissue boundaries as seen in ischaemia and inflammation.

The abstract can be read in the latest online issue of the British Journal of Ophthalmology.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.